Catalyst Funds Management’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,800
Closed -$85.3K 1461
2024
Q1
$85.3K Buy
+5,800
New +$85.3K 0.02% 435